Results per Page:
Towards accessible gene therapy: in vivo base editing to cure Sickle Cell Disease
From the Cancer Consortium Lieber Lab, Department of Laboratory Medicine and Pathology, University of Washington
From humans, to mice, to plants: sometimes a little poison is a good thing
From The Bradley Lab, Public Health Sciences and Basic Sciences Divisions.
Understanding how microbial imbalances may influence Juvenile Dermatomyositis, a rare immune-mediated disease
From the Dey Lab, Pathogen Associated Malignancies Program of the Cancer Consortium
El momento en que se administra la TAR para el VIH es más importante de lo que imaginábamos
De los grupos de los doctores Edlefsen y Frenkel, Consorcio Oncológico
Menopausal hormone therapy may lower the risk of colorectal cancer
From the Peters and Hsu Groups, Cancer Consortium & Public Health Sciences Division
Timing of ART administration for HIV is more important than we thought
From the Edlefsen and Frenkel Groups, Cancer Consortium
10 Washington groups take on cancer health disparities with grants from Fred Hutch
Community Grants Program funds projects statewide to improve cancer outcomes and build organizational capacity
Neuron-glia love triangles at single-cell resolution
From the Singhvi Lab, Basic Sciences Division
Mechanical coupling helps microtubules coordinate chromosomal separation
From the Asbury lab, University of Washington and Biggins lab, Fred Hutch Basic Sciences Division, Cancer Consortium Cancer Basic Biology Program
A coordinated care approach rapidly gets COVID-19 therapy into the hands of high-risk cancer patients
From Drs. Eduardo Sanchez, Steven Pergam, and Catherine Liu, ,Fred Hutch Vaccine and Infectious Diseases Division and Cancer Consortium Hematologic Program
Using mathematical models to tell time of initial HIV infection in infants
From the Overbaugh/Lehman Lab, Cancer Consortium and Human Biology Division
From predicted neoantigen to T cell therapy for acute myeloid leukemia
From the Bleakley Lab, Cancer Consortium and Translational Science & Therapeutics Division
A niche topic: understanding the development of hematopoietic stem cells
From the Hadland and Bernstein labs, Translational Science and Therapeutics Division
New projects advance health equity research
Two $1M grants support efforts to pinpoint novel prostate cancer biomarkers, improve clinical trial enrollment and inclusion
Macrophages predict response to immunotherapy in Merkel cell carcinoma
From the Nghiem lab, Fred Hutch Clinical Research Division & UW Dermatology
A new cell type with links to gastric cancer steps up for its mugshot
From the Salama Lab, Human Biology Division
AI rides shotgun in the quest for better cancer diagnostics
From the Liu Lab, UW College of Engineering and School of Medicine, and the Grady Lab, Translational Science and Therapeutics and Public Health Sciences Divisions
Is it cancer? A combination non-invasive approach to determine if indeterminate pulmonary nodules are cancerous
From Dr. Paul Lampe, Translational Research Program and Cancer Epidemiology, Prevention and Control of the Cancer Consortium, and Dr. Paul Kinahan, University of Washington.
CAF-like cells remodel the Ewing sarcoma tumor microenvironment
From the Lawlor lab, Seattle Children’s Hospital and the Cancer Basic Biology Program of the Cancer Consortium
A promising program for cancer intervention in rural communities
From the Health Communication Research Center, Public Health Sciences Division and the Cancer Epidemiology, Prevention and Control Program of the Cancer Consortium